CluenexVersigent VGNT
Versigent scores good on business quality (6.0 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What Versigent does
Versigent designs and manufactures auto components, selling parts directly to vehicle makers to keep assembly lines moving. The firm is scaling up its production footprint while prepping for its upcoming third-quarter earnings call.
- What it does best
Versigent generates a net margin of 5.4% on $13.5B in revenue, outperforming APTV which sits at a 4.1% FCF margin. This efficiency comes from deep manufacturing integration that rivals struggle to match.
- The main risk
Rising input costs threaten the thin operating margin of 7.7%, leaving little cushion if supply chain expenses tick upward.
Quality, check by check
Scored against its own industry, from company filings.
Operating margin stands at 7.7% and FCF margin sits near 4%, but a low 2.0 profitability score shows the business struggles to retain earnings as it scales.
Versigent locks in major automakers through tight supply chain integration, though its gross margin ranks in the bottom quartile of its sector at 12.3%.
Revenue grew 6.1% to $13.5B, showing steady acceleration compared to the prior year's flat $8.8B figure.
Debt-to-equity sits at a minimal 0.04 with interest coverage at 25x, meaning debt costs are easily managed. Free cash flow reached $558M, showing the balance sheet is getting stronger.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
No open market buys or unplanned sales by executives or directors.
Our sealed record on VGNT
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
Versigent scores good on the Cluenex quality check (6.0 of 10), measured against its own industry. Profitability is weak, moat strong, growth steady and financial health strong.
In the last 90 days of SEC Form 4 filings: No open market buys or unplanned sales by executives or directors.
Nov 4, 2026.
See VGNT today
- Today's verdict on VGNT, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “Versigent (VGNT)”, https://cluenex.com/stocks/vgnt/, data as of Oct 10, 2026.